Our information clearly show that CK18 is continually expressed in several epithelial cancers, In particular adenocarcinomas. each loss of CK18 expression in cancers derived from CK18 constructive precursor cells and neo-expression in malignancies derived from CK18 optimistic precursors are usually linked to unfavorable tumor phenotype and illness